» Articles » PMID: 39719705

3D Chromatin Hubs As Regulatory Units of Identity and Survival in Human Acute Leukemia

Abstract

Cancer progression involves genetic and epigenetic changes that disrupt chromatin 3D organization, affecting enhancer-promoter interactions and promoting growth. Here, we provide an integrative approach, combining chromatin conformation, accessibility, and transcription analysis, validated by in silico and CRISPR-interference screens, to identify relevant 3D topologies in pediatric T cell leukemia (T-ALL and ETP-ALL). We characterize 3D hubs as regulatory centers for oncogenes and disease markers, linking them to biological processes like cell division, inflammation, and stress response. Single-cell mapping reveals heterogeneous gene activation in discrete epigenetic clones, aiding in patient stratification for relapse risk after chemotherapy. Finally, we identify MYB as a 3D hub regulator in leukemia cells and show that the targeting of key regulators leads to hub dissolution, thereby providing a novel and effective anti-leukemic strategy. Overall, our work demonstrates the relevance of studying oncogenic 3D hubs to better understand cancer biology and tumor heterogeneity and to propose novel therapeutic strategies.

Citing Articles

Native stem cell transcriptional circuits define cardinal features of high-risk leukemia.

Wang Q, Boccalatte F, Xu J, Gambi G, Nadorp B, Akter F J Exp Med. 2025; 222(4).

PMID: 39969525 PMC: 11837855. DOI: 10.1084/jem.20231349.


The common murine retroviral integration site activating Hhex marks a distal regulatory enhancer co-opted in human early T-cell precursor leukemia.

Hardwick J, Rodriguez-Hernaez J, Gambi G, Venters B, Guo Y, Li L J Biol Chem. 2025; 301(3):108233.

PMID: 39880094 PMC: 11889976. DOI: 10.1016/j.jbc.2025.108233.